MSB 0.54% 92.0¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-652

  1. 12,523 Posts.
    lightbulb Created with Sketch. 3391
    Really? The vote was 9-1. What do you think the ODAC recommendation would be?

    “The Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of cancer and makes appropriate recommendations to the Commissioner of Food and Drugs.”
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
92.0¢
Change
-0.005(0.54%)
Mkt cap ! $1.053B
Open High Low Value Volume
92.0¢ 92.5¢ 91.5¢ $1.133M 1.233M

Buyers (Bids)

No. Vol. Price($)
13 151980 91.5¢
 

Sellers (Offers)

Price($) Vol. No.
92.0¢ 29989 2
View Market Depth
Last trade - 16.10pm 18/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.